Logo

Media overview

Services
Remove all filters
The Bird trial is a Belgian Real-world study
The Bird trial is a Belgian Real-world study where 334 patients with Chronic lymphocytic leukemia, Mantle Cell lymphoma or Waldenstrom Macroglobulinemia are being treated with Ibrutinib.
Imbruvica
Audio
Is precision treatment of KRAS mutant NSCLC advancing? What is the best strategy?
Prof. Dr. I. Demedts, AZ Delta, Roeselare
Dr. A. Sibille, CHU de Liège
Dr. L. Pirard, CHU UCL Namur, Godinne
Video
What lies beyond the osimertinib horizon?
Dr. C. De Bondt, Universitair Ziekenhuis Antwerpen
Prof. Dr. J. Vansteenkiste, Universitair Ziekenhuis Leuven
Dr. L. Van Den Bosch, Universitair Ziekenhuis Antwerpen
Video
Is there a place for chemo- and immunotherapy combination in patients with high PD-L1 expression?
Dr. K. Cuppens, Jessaziekenhuis, Hasselt
Prof. Dr. K. Vermaelen, Universitair Ziekenhuis Gent
Dr. B. Forier, Universitair Ziekenhuis Leuven
Video
Is there a place for immunotherapy for tumors with oncogenic driver mutations?
Prof. Dr. T. Berghmans, Institut Jules Bordet, Bruxelles
Dr. F. Aboubakar Nana, Cliniques Universitaires St-Luc, Bruxelles
Dr. M. Brandao, Institut Jules Bordet, Bruxelles
Video
Immunology-Meded-Rheumatology-Podcasts-Part1
Rheumatology in 2030 - part 1:
The future of rheumatology looks promising. In part 1 of this two-part, visionary podcast series "Rheumatology in 2030", Prof. Dr. Dirk Elewaut (UZ Gent) and Prof. Dr. Margreet Kloppenburg (Leiden University Medical Center) look ahead to the next 10 years of their specialism with a lot of optimism.
Rheumatology
Audio
Immunology-Meded-Rheumatology-Podcasts-Part2
Rheumatology in 2030 - part 2
More adminstrative tasks and less time for qualitative interactions with your patients. Will this be the future of rheumatology? Preferrably not! In part 2 of this two-part, visionary podcast series "Rheumatology in 2030", Prof. Dr. Dirk Elewaut (UZ Gent) and Prof. Dr. Margreet Kloppenburg (Leiden University Medical Center) share their views on how technological advancements could allow you to spend more time with your patients, but also how the ever changing healthcare system might look like.
Rheumatology
Audio
One year on: an update on imid management during the pandemic
This webinar addresses issues that healthcare providers may face when they treat patients with immune-mediated inflammatory diseases (IMIDs) during the COVID-19 pandemic.
Gastroenterology
Immunology
Video
Highlights of AAD VMX 2021
This webinar provides an update on the newest developments in the field of inflammatory skin diseases that were presented at AAD VMX 2021 (23-25 April 2021).
Dermatology
Immunology
Video
One year on: an update on IMID management during the pandemic
This webinar addresses issues that healthcare providers may face when they treat patients with immune-mediated inflammatory diseases (IMIDs) during the COVID-19 pandemic.
Immunology
Rheumatology
Video
Prof. Thierry Facon on DARZALEX® + lenalidomide + dexamethasone (DRd)
The lead author of the MAIA study, Prof. Thierry Facon explains the study design and key efficacy and safety results.
Darzalex